Cancer Research | Penn Today

A cancer patient holding hands with a relative in consult with a doctor in a hospital bed.

Data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

A new Penn Medicine study finds indefinite immunotherapy is not associated with improved survival in large, retrospective cohort.

Why new cancer treatment discoveries are proliferating

The approval of CAR T cell therapy ushered in a new era for cancer treatment.

The path from innovation to implementation

Penn’s infrastructure in both supporting clinical research and forging commercial partnerships smooths the way from idea to approval.

A man sits with a doctor holding an iPad.

Three things to know about BRCA mutations in men

Kara Maxwell, director of the Men & BRCA Program at the Basser Center, is bridging the knowledge gap about how BRCA mutations affect men.

Improved gene editing method could power future cell and gene therapies

A new technique based on special cell-penetrating peptides promises advantages over current methods for editing the genomes of primary cells, such as patients’ T cells.

Pancreatic cancer vaccine shows promise in small initial trial

Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness.

Aerial image of Penn Medicine staff in the atrium celebrating.

Why Penn research powers many FDA-approved treatments

Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.

Cutting-edge advances in cancer treatment are underway. Here are three that could change lives

Robert Vonderheide and Constantinos Koumenis of the Perelman School of Medicine discuss the major advancements occurring in cancer surgery and cancer radiation, two fundamental tools of cancer treatment.

Three people participate in an organized run and walk, wearing matching t-shirts

Running and walking for oral cancer awareness

In a student-led effort, the School of Dental Medicine hosted the Oral Cancer Walk & 5K. The event has been an annual tradition since 2009, offering both a community celebration and a venue for discussing oral cancer prevention and detection.

Moderna, Merck show progress toward cancer vaccines

Robert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients.

Filters